SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Pharmaceuticals - Quaterly Results

09 Nov 2025 Evaluate
The Revenue for the quarter ended  September 2025 of Rs. 2424.30 millions grew by 23.22 % from Rs. 1967.48 millions.Profit for the quarter ended September 2025 rises by 76.36% to Rs. 251.44  millions from Rs. 142.57 millions.Operating Profit saw a handsome growth to 498.13 millions from 331.65 millions in the quarter ended September 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 2424.30 1967.48 23.22 4384.77 3611.99 21.39 7827.48 7092.63 10.36
Other Income 14.34 13.05 9.89 20.27 26.73 -24.17 62.24 44.60 39.55
PBIDT 498.13 331.65 50.20 892.67 679.98 31.28 1461.98 1213.04 20.52
Interest 57.36 46.06 24.53 115.76 92.73 24.84 185.41 234.57 -20.96
PBDT 440.77 285.59 54.34 776.91 587.25 32.30 1276.57 978.47 30.47
Depreciation 100.21 86.20 16.25 197.73 170.02 16.30 343.37 315.16 8.95
PBT 340.56 199.39 70.80 579.18 417.23 38.82 933.20 663.31 40.69
TAX 89.12 56.82 56.85 145.66 111.38 30.78 249.39 169.07 47.51
Deferred Tax 6.62 9.82 -32.59 13.16 11.38 15.64 52.99 17.79 197.86
PAT 251.44 142.57 76.36 433.52 305.85 41.74 683.81 494.24 38.36
Equity 93.65 84.65 10.63 93.65 84.65 10.63 88.65 84.65 4.73
PBIDTM(%) 20.55 16.86 21.90 20.36 18.83 8.14 18.68 17.10 9.21

SMS Pharmaceuticals Share Price

427.60 3.45 (0.81%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×